Improving adult vaccination rates among healthcare providers
Official title: RFA-IP23-002 Adult Immunization Quality Improvement for Providers (IQIP)
Funded at Johns Hopkins University · NIH-10899402 · Data updated 2026-11-12
This study is working to help doctors and healthcare providers improve the number of adults getting vaccinated by creating a special program that gives them the tools and support they need to do a better job.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | September 1, 2023 |
| Project end | August 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $494,850 |
| NIH project number | 5U01IP001201-02 |
| Project ID | NIH-10899402 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults who are due for vaccinations or those who may benefit from increased immunization efforts.
✕Less likely to help
Patients who are not eligible for vaccinations or those who are already fully vaccinated may not receive direct benefits from this research.
What this research studies
This project aims to enhance adult immunization rates by implementing a Quality Improvement (QI) program tailored specifically for healthcare providers. The approach involves assessing current practices, developing a structured Adult Immunization QI Program, and providing ongoing support and evaluation to ensure its effectiveness. By focusing on evidence-based strategies, the program seeks to create a sustainable model for increasing vaccination among adults across various healthcare settings.
Why it matters
Potential benefit: If successful, this research could lead to significantly higher rates of adult vaccinations, improving overall public health.
How similar studies have gone: Previous initiatives focusing on quality improvement in immunization have shown success in increasing vaccination rates, indicating that this approach is promising.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Salmon, Daniel a — Johns Hopkins University
- Study coordinator: Salmon, Daniel a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.